Adamis Pharmaceuticals Corporation Gains 40.6%
Thu, Aug 03, 2023 at 07:34 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) rocketted at $1.87, a gain of 40.6%. The stock appeared on our News Catalysts scanner on Wed, Aug 02, 2023 at 09:05 AM in the 'PUBLIC OFFERING' category. From Thu, Jul 20, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Aug 01, 2023 at $8.28 with a volume of 20M+.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Electriq Power Holdings Inc. Class A (ELIQ:NYSE), 59.15%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 52.2%
- Upwork Inc. (UPWK:NASDAQ), 44.23%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 44.03%
- Traeger Inc. (COOK:NYSE), 41.99%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 40.6%
- Sabre Corporation (SABR:NASDAQ), 32.52%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 30.4%
- Motorsport Games Inc. (MSGM:NASDAQ), 28.86%
- Viacom Inc. (VIA:NASDAQ), 28.61%